Alzheimer C, ten Bruggencate G
Department of Physiology, University of Munich, Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Apr;337(4):429-34. doi: 10.1007/BF00169535.
The effects of the purported K+ channel opener BRL 34915 upon CNS neurons were examined in guinea pig hippocampal slices. Both the EPSP component and the population spike of field potentials recorded in the CA1 area were reduced in amplitude by BRL 34915 (EC50 about 100 mumol/l). In the same concentration range, BRL 34915 also slowed down the bursting rate of pacemaker neurons in the CA3 region. In order to test a possible anticonvulsant efficacy of the drug, the excitability of hippocampal neurons was increased experimentally by changing the ionic composition of the perfusion medium (omission of Ca2+ or Mg2+, elevation of K+). In all three conditions, epileptiform neuronal activity occurred, which was depressed by BRL 34915. The similarity of the effects of BRL 34915 in normal and convulsive slices indicates that the compound acts upon intrinsic nonsynaptic processes controlling neuronal excitability and cell firing.
在豚鼠海马切片中研究了据称的钾通道开放剂BRL 34915对中枢神经系统神经元的作用。BRL 34915(半数有效浓度约为100μmol/L)使CA1区记录的场电位的兴奋性突触后电位成分和群体峰电位的幅度降低。在相同浓度范围内,BRL 34915还减慢了CA3区起搏神经元的爆发频率。为了测试该药物可能的抗惊厥疗效,通过改变灌流介质的离子成分(省略Ca2+或Mg2+、升高K+)来实验性地增加海马神经元的兴奋性。在所有三种情况下,均出现癫痫样神经元活动,且被BRL 34915抑制。BRL 34915在正常切片和惊厥切片中的作用相似,表明该化合物作用于控制神经元兴奋性和细胞放电的内在非突触过程。